Cardinal Health, Inc. raised its earnings guidance for fiscal year 2024. For the period, the company expects non-GAAP diluted earnings per share attributable to $7.30 to $7.40, from $7.20 to $7.35. This guidance includes an update to the company?s Pharmaceutical and Specialty Solutions segment profit outlook to 8.5% to 9.5% growth, from 7% to 9% growth.